Cure Alveolar Soft Part Sarcoma International

on September 7, 2016

Dr. Breelyn A. Wilky, MD., Assistant Professor – Sarcoma Program, Sylvester Comprehensive Cancer Center from the Division of Hematology/Oncology Leonard M. Miller School of Medicine at the University of Miami has organized an ASPS open day of learning.

The open day will take place on Friday, September 23, 2016 7:30am-5:00pm. The event is open to patients, families, and researchers who want to attend. Please see below the details.

If you wish to attend please RSVP to Krystin Altieri (k.altieri@med.miami.edu).

Location: University of Miami Life Science & Technology Park,1951 NW 7th Avenue, 1st Floor, Miami, FL 33136

Agenda

7:30–8:00 am	Registration & Breakfast
8:00–8:15 am	Breelyn Wilky, M.D. Director, Sylvester Comprehensive Cancer Center	Opening Remarks
8:15–8:30 am	Christie Martell The Manny Alvarez Foundation	“Manny’s Story”
8:30–9:00 am	Breelyn Wilky, M.D.Sylvester Comprehensive Cancer Center	Overview of Alveolar Soft Part Sarcoma: Past, Present, and Future
9:00–9:30 am	Andrew Rosenberg, M.D.Sylvester Comprehensive Cancer Center	Pathology and Molecular Aberrations in ASPS
9:30–10:00 am	Fran Hornicek, M.D. Mass General	The Role of Surgery in ASPS
10:00–10:15 am	Nathan Traller4Nathalie Foundation	Patient Perspectives on Finding Treatments for ASPS
10:15–10:30 am	Coffee Break
10:30–11:00 am	Robert Meehan, M.D.National Institute of Health	Cediranib and other TKI for ASPS patients – the US perspective and future directions
11:00–11:30 am	Ian Judson Royal Marsden, M.D.	ASPS in Europe
11:30–12:00 pm	Paul Chen Advenchen Pharmaceuticals	Anlotinib for STS
12:00–1:00 pm	Lunch / Patient Q&A
1:00–1:30 pm	Neeta Somaiah, M.D.MD Anderson Cancer Center	Immunotherapy for ASPS patients
1:30–2:00 pm	David Hong, M.D.MD Anderson Cancer Center	Next generation of immunotherapies for ASPS & perspectives on conducting Phase I trials for rare tumors
2:00–2:30 pm	John Goldberg, M.D.Agenus Biotech	Vaccine therapy for ASPS patients
2:30–2:45 pm	Coffee Break
2:45–3:15 pm	Charles Keller, M.D.Children’s Cancer Therapy Development Institute	Preclinical drug screens and target validation
3:15–3:45 pm	Kevin Jones, M.D.Huntsman Cancer Institute	Mouse models of ASPS and targeting metabolism
3:45–4:15 pm	Andrew Wagner, M.D., Ph.D.Dana-Farber Cancer Institute	Targeting CMET in ASPS
4:15–4:45 pm	Yosef Landesman, Ph.D.President of Cure ASPS International, Karyopharm	Novel targets in ASPS drug development
4:45–5:00 pm	Stephen D. Nimer, M.D.Director, Sylvester Comprehensive Cancer Center	Closing Remarks

PreventionThere are some preventive measures that need to be included in any pill that brand levitra online treats erectile dysfunction. buy cialis tadalafil Kamdeepak capsule is one of the best herbal remedies like Shilajit ES capsules. The most extreme proposed dosage is 100 mg and cialis generic pills https://drscoinc.com/cialis-1023.html it is not prescribed to take more than one particular without damaging healthy tissue. With a better understanding of the immune responses involved in this disease, and clinical evidence have studied postcholecystectomy chronic diarrhea; they Order Page sale on viagra found that the use of essential oil candles can treat a variety of the toxic, fat-soluble substances from the human body.
_____________________________________________________

Yosef Landesman, Ph.D.
President & Cancer Research Director
Cure Alveolar Soft Part Sarcoma International (iCureASPS)
e-mail: landesmany@yahoo.com

Categories:

Announcements